GT Biopharma (OTCQB: GTBP), an immuno-oncology company focused on innovative therapies based on the company’s proprietary TriKE(TM) technology platform, has released the pricing of its recent underwritten public offering of 4,300,000 units. The offering will be priced at $5.50 per unit or prefunded unit, with a unit consisting of one share of the company’s common stock and one warrant to purchase one share of its common stock. The company anticipates gross proceeds from the public offering to reach an estimated $23.6 million customer deductions. In the announcement, the company noted that it has also granted a 45-day over-allotment options to the underwriters that allows for the purchase of an additional 645,000 units. For this offering, the company may issue a prefunded unit in lieu of a unit. GT Biopharma anticipates the offering to close on Feb. 16, 2021; the offering will be subject to customary closing conditions. In addition to announcing the public offering pricing, GT Biopharma announced that it has been approved for listing common stock on the Nasdaq Capital Market, trading under its existing ticker symbol, GTBP (“GTBP”) at the opening of market hours on Thursday, Feb. 11, 2021. Roth Capital Partners and Dawson James Securities, Inc. are acting as joint book-running managers for the offering.
To view the full press release, visit https://ibn.fm/z1Ycl
About GT Biopharma Inc.
GT Biopharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on its proprietary TriKE(TM) NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer-killing abilities of a patient’s immune system natural killer cells (“NK cells”). GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology. For more information about the company, please visit www.GTBiopharma.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php